These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 6415264

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].
    Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Noguchi M, Yamauchi H, Shimizu H.
    Jpn J Antibiot; 1982 Sep; 35(9):2163-73. PubMed ID: 7143717
    [Abstract] [Full Text] [Related]

  • 3. [Studies on beta-lactam antibiotics for medicinal purpose. XIV. Stability and degradation pattern of sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4- carboxylate (T-1982) in aqueous solution].
    Takano S, Tai M, Sakai H, Takakura I, Ochiai H, Sugimoto Y, Fukuoka Y, Saikawa I.
    Yakugaku Zasshi; 1983 Jan; 103(1):62-72. PubMed ID: 6864450
    [No Abstract] [Full Text] [Related]

  • 4. [Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)].
    Saikawa I, Nakashima Y, Sakai H, Momonoi K, Ikegami T, Minami H, Hayakawa H, Ochiai H, Todo Y.
    Yakugaku Zasshi; 1980 Jun; 100(6):625-40. PubMed ID: 6450829
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Studies on the absorption distribution and excretion of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-alpha-(4-hydroxyphenyl l) acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].
    Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Takagi T, Yamauchi H.
    Jpn J Antibiot; 1980 Oct; 33(10):1084-96. PubMed ID: 6451722
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The autoradiographic studies on the distribution of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)-acetamido]-3-[(1-methyl -1 H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].
    Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Takagi T, Yamauchi H.
    Jpn J Antibiot; 1980 Oct; 33(10):1097-103. PubMed ID: 6451723
    [Abstract] [Full Text] [Related]

  • 11. [Studies on beta-lactam antibiotics for medicinal purpose. VI. Studies on the metabolism of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-phenylacetamido]penicillanic acid (T-1220) (author's transl)].
    Saikawa I, Takai A, Nakashima Y, Yoshida C, Yasuda T.
    Yakugaku Zasshi; 1977 Oct; 97(10):1071-81. PubMed ID: 412944
    [No Abstract] [Full Text] [Related]

  • 12. [Studies on beta-lactam antibiotics for medicinal purposes. XXII. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (2)].
    Saikawa I, Nakajima Y, Tai M, Sakai H, Demachi K, Kajita T, Hayakawa H, Onoda M, Fukuda H, Sadaki H.
    Yakugaku Zasshi; 1986 Jun; 106(6):478-90. PubMed ID: 3761158
    [No Abstract] [Full Text] [Related]

  • 13. Straightforward synthesis of 7 alpha-methoxy-1-oxacephems from penicillins.
    Nagata W.
    Philos Trans R Soc Lond B Biol Sci; 1980 May 16; 289(1036):225-30. PubMed ID: 6109318
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). III. Effect on smooth-muscle organs (author's transl)].
    Takai A, Hirai S, Watanabe I, Hiraiwa T, Omori M.
    Jpn J Antibiot; 1977 Aug 16; 30(8):557-70. PubMed ID: 909144
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). II. Effect on circulatory system and blood (author's transl)].
    Takai A, Hirai S, Hiraiwa T, Watanabe I, Omori M.
    Jpn J Antibiot; 1977 Aug 16; 30(8):543-56. PubMed ID: 909143
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl]-1 H-benzimidazole-7-carboxylate. Part II: Effect on cardiovascular system and renal functions.
    Kito G, Ito K, Shiomi M.
    Arzneimittelforschung; 1996 Jul 16; 46(7):681-6. PubMed ID: 8842337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.